Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) said Tuesday the U.S. Food and Drug Administration has removed the clinical hold on sovaprevir, the company’s experimental hepatitis C treatment. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) weekly performance is 189.59%. On last trading day company shares ended up $7.79. Analysts mean target price for the company is $5.44. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) distance from 50-day simple moving average (SMA50) is 169.74%.
Jun 5, 2014, UniPixel, Inc. (NASDAQ:UNXL), a provider of Performance Engineered Films™ to the touch screen, flexible printed electronics and display markets, will hold a conference call on Wednesday, June 25, 2014 at 4:30 p.m. Eastern time to discuss the company’s progress towards achieving a reliable, high-volume, roll-to-roll production process for its projected capacitive, multi-touch sensor films. UniPixel Inc (NASDAQ:UNXL) shares advanced 14.96% in last trading session and ended the day on $9.22. Its return on assets is -39.10%. UniPixel Inc (NASDAQ:UNXL) quarterly performance is -3.86 %.
Zynga Inc (NASDAQ:ZNGA)‘s concerns are deepening as it plans to hop onto the mobile-first, content-centric organization. ZNGA’s plans are going haywire and its efforts in vain as daily or monthly user counts are fizzling out, dwindling profits. Zynga Inc (NASDAQ:ZNGA) is truly passing through scorching times – periods of double whammies. It has witnessed cliff-falls in user counts for all of its top 12 games except for Farm Ville 2, and its senior executives are quitting; lately, ZNGA’s cofounder— Mark Pincus relinquished the last days of his operational duty at the company on April 24, 2014. Zynga Inc (NASDAQ:ZNGA) shares moved up 6.67% in last trading session and was closed at $3.20, while trading in range of $3.06 – $3.22. Zynga Inc (NASDAQ:ZNGA) year to date (YTD) performance is -15.79%.
Chico’s FAS, Inc. (NYSE:CHS) a specialty women’s clothing retailer based in Fort Myers, may be going private. Financial Times, quoting unnamed sources, said Chico’s executives have had talks with several private equity groups in recent weeks. The talks are in the early stages, the sources said, and the company could decide not to sell or sell just a part of the company. Chico’s FAS, Inc. (NYSE:CHS) ended the last trading day at $16.53. Company weekly volatility is calculated as 2.20% and price to cash ratio as 14.77. Chico’s FAS, Inc. (NYSE:CHS) showed a positive weekly performance of 7.90%.
On May 28, Looking to extend its skin care unit, Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) will pay $1.4 billion in cash for the right to sell products made by Valeant Pharmaceuticals, Bloomberg reported. Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) On last trading day company shares ended up $77.39 .